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Post-operative acute kidney injury (AKI) is a common complication of surgery. Rates 
vary according to type of surgery ranging from 13% following GI surgery and 10% 
after orthopaedic surgery to 26% following cardiac surgery to [1-3]. 
Understanding the aetiology of post-operative AKI is vital to peri-operative 
optimisation. However, the pathogenesis is complex and usually multifactorial 
(Figure 1). Renal hypoperfusion plays an important role in post-operative AKI. This 
can occur as a result of a number of different factors including hypovolaemia, loss of 
autoregulation during anaesthesia, cardiogenic shock, sepsis and high risk 
medicines such as non-steroid anti-inflammatory drugs (NSAIDs) and inhibitors of 
the renin-angiotensin system.  
Cardiac surgery is associated with particularly high rates of AKI. Contributing factors 
unique to cardiac surgery include the use of intra-aortic balloon bumps and 
cardiopulmonary bypass (CPB). CPB can lead to AKI through a number of 
mechanisms. These include inflammation, ischemia reperfusion injury and 
haemodilution. Contact of blood products with the CPB circuit leads to a systemic 
inflammatory response and ischaemia reperfusion injury. The shear stress also 
incites red cell lysis and release of free haemoglobin which subsequently releases 
iron in the presence of oxidants causing tissue damage. Haemodilution from priming 
of the CPB circuit is also associated with AKI. This is thought to be due to reduced 
oxygen delivery. Finally, cholesterol emboli can occur from aortic manipulation and 
clamping during CBP. 
The importance of preventing post-operative AKI has been highlighted by the 
increasing observational data demonstrating adverse outcomes in patients with even 
mild, transient episodes of AKI.  These include increased mortality, increased risk of 
developing chronic kidney disease and longer hospital in-patient stays with resulting 
economic implications [1, 2]. 
Identifying patients at high risk of AKI facilitates closer monitoring allowing for peri-
operative optimisation. Several validated risk scores have been developed for use in 
patients undergoing cardiac surgery. Fewer risk scores have been developed for 
patients undergoing non-cardiac surgery. Most of these risk scores include both 
patient and operation related risk factors with the most common risk factors shown in 
Figure 1. There is, however, a lack of defined interventions once these patients have 
been identified.  
Multiple pharmacological agents have been studied in the peri-operative period. 
Loop diuretics have consistently been shown to offer no benefit and possibly harm 
and so are not recommended unless in the context of fluid overload. Vasodilator 
therapy such as dopamine, fenoldopam and atrial natriuretic peptide (ANP) were 
thought to be beneficial as they increase glomerular filtration rate through renal 
vasodilation and natriuresis. Once again this benefit has not been shown in clinical 
studies with the possibility that these agents may even lead to harm[4]. Similarly, N-
acetylcysteine, 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors 
(statins), aspirin and clonidine have been shown to be ineffective. 
Whilst there are a lack of interventions that reduce the risk of AKI, there is evidence 
to suggest that avoidance of certain medications in the peri-operative period may 
reduce the risk of post-operative AKI. NSAIDs are effective analgesics commonly 
used to treat post-operative pain but can lead to AKI through inhibition of 
prostaglandins leading to loss of afferent arteriolar vasodilation.  Similarly, 
aminoglycosides use in the peri-operative period has been associated with increased 
rates of AKI even at low doses used as surgical prophylaxis [5]. There is conflicting 
evidence with regards to the avoidance of inhibitors of the renin–angiotensin system 
in the peri-operative period with studies showing that continuation may in fact lower 
rates of AKI[6]. These data are largely observational thereby subject to confounding. 
In the absence randomized control trial evidence and their well described effects on 
glomerular filtration rate, it would seem logical to withhold these agents in the peri-
operative period.   The use of contrast media in the peri-operative period is more 
controversial with increasing evidence suggesting that the risks of intravenous 
contrast are overstated[7]. Therefore, there appears to be no need to limit CT scan 
quality by avoiding the administration of contrast media in the peri-operative period. 
Peri-operative haemodynamic optimization to maintain renal perfusion is an 
important means of preventing post-operative AKI. Periods of intra-operative 
hypotension with a mean arterial pressure (MAP) of less than 60mm Hg are 
associated with increased rates of AKI.  However, it is important to note that fluid 
overload is associated with increased mortality and aggravate AKI by causing a 
reduction in GFR through increased subcapsular pressure and abdominal 
compartment syndrome[8]. Striking the balance between adequate fluid resuscitation 
whilst avoiding fluid overload is important in the peri-operative period but often 
difficult to achieve in practice. 
Choice of intravenous fluid therapy is emerging as an important factor in the 
development of post-operative AKI. Hydroxyethyl starches have been associated 
with AKI in several studies and so their use is no longer recommended in any 
context [9]. There is also concern regarding the high chloride content of 0.9% saline 
which has been associated with hyperchloreamic acidosis, renal vasoconstriction 
and AKI [10]. These concerns have led to the increasing use of balanced crystalloid 
solutions. 
Two recent studies have evaluated the effect of a “KDIGO bundle” in patients 
defined as high risk using the urinary biomarker (inhibitor of metalloproteinase-2 x 
insulin-like growth factor–binding protein 7) [TIMP-2]·[IGFBP7]  >0.3. This bundle 
comprises of optimization of volume status and haemodynamics and avoidance of 
nephrotoxic drugs. Meersch et al found reduced rates and severity of AKI in patients 
undergoing cardiac surgery compared to standard care[11]. Similarly, a study of 
patients undergoing major abdominal surgery showed reduced rates, severity of AKI, 
and length of hospital stay following implementation of this care bundle[12]. 
However, this biomarker is not currently in routine use but may provide a future 
means of risk stratification coupled with an effective intervention. Further studies are 
required to confirm these findings. 
Conclusion 
Surgery is an important cause of AKI and is associated with adverse outcomes. 
Identifying patients at high risk of AKI may allow for peri-operative optimisation and 
closer monitoring. Biomarkers are emerging as a potentially important tool in early 
risk stratification. There are no pharmacological agents that reduce or prevent post-
operative AKI. Identification of high risk individuals, haemodynamic optimization and 
careful fluid balance management, avoidance of high risk medicines in the peri-
operative period and monitoring of renal function are likely to be beneficial. 
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